These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33240758)

  • 1. MYSM1 Suppresses Cellular Senescence and the Aging Process to Prolong Lifespan.
    Tian M; Huang Y; Song Y; Li W; Zhao P; Liu W; Wu K; Wu J
    Adv Sci (Weinh); 2020 Nov; 7(22):2001950. PubMed ID: 33240758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional differences of SWIRM domain subtypes.
    Yoneyama M; Tochio N; Umehara T; Koshiba S; Inoue M; Yabuki T; Aoki M; Seki E; Matsuda T; Watanabe S; Tomo Y; Nishimura Y; Harada T; Terada T; Shirouzu M; Hayashizaki Y; Ohara O; Tanaka A; Kigawa T; Yokoyama S
    J Mol Biol; 2007 May; 369(1):222-38. PubMed ID: 17428495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.
    Le Guen T; Touzot F; André-Schmutz I; Lagresle-Peyrou C; France B; Kermasson L; Lambert N; Picard C; Nitschke P; Carpentier W; Bole-Feysot C; Lim A; Cavazzana M; Callebaut I; Soulier J; Jabado N; Fischer A; de Villartay JP; Revy P
    J Allergy Clin Immunol; 2015 Dec; 136(6):1619-1626.e5. PubMed ID: 26220525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYSM1 Represses Innate Immunity and Autoimmunity through Suppressing the cGAS-STING Pathway.
    Tian M; Liu W; Zhang Q; Huang Y; Li W; Wang W; Zhao P; Huang S; Song Y; Shereen MA; Qin M; Liu Y; Wu K; Wu J
    Cell Rep; 2020 Oct; 33(3):108297. PubMed ID: 33086059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myb-like, SWIRM, and MPN domains 1 (MYSM1) deficiency: Genotoxic stress-associated bone marrow failure and developmental aberrations.
    Bahrami E; Witzel M; Racek T; Puchałka J; Hollizeck S; Greif-Kohistani N; Kotlarz D; Horny HP; Feederle R; Schmidt H; Sherkat R; Steinemann D; Göhring G; Schlegelbeger B; Albert MH; Al-Herz W; Klein C
    J Allergy Clin Immunol; 2017 Oct; 140(4):1112-1119. PubMed ID: 28115216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of H2A deubiquitinase 2A-DUB/Mysm1 and the p19(ARF)/p53 axis in hematopoiesis, early T-cell development and tissue differentiation.
    Gatzka M; Tasdogan A; Hainzl A; Allies G; Maity P; Wilms C; Wlaschek M; Scharffetter-Kochanek K
    Cell Death Differ; 2015 Sep; 22(9):1451-62. PubMed ID: 25613381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYSM1 induces apoptosis and sensitizes TNBC cells to cisplatin via RSK3-phospho-BAD pathway.
    Guan X; Meng X; Zhu K; Kai J; Liu Y; Ma Q; Tong Y; Zheng H; Xie S; Ma X; Wang Y; Lu R; Guo L
    Cell Death Discov; 2022 Feb; 8(1):84. PubMed ID: 35217648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deubiquitinase catalytic activity of MYSM1 is essential in vivo for hematopoiesis and immune cell development.
    Liang Y; Bhatt G; Tung LT; Wang H; Kim JE; Mousa M; Plackoska V; Illes K; Georges AA; Gros P; Henneman L; Huijbers IJ; Nagar B; Nijnik A
    Sci Rep; 2023 Jan; 13(1):338. PubMed ID: 36611064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mysm1 expression in the bone marrow niche is not essential for hematopoietic maintenance.
    Petrov JC; Nijnik A
    Exp Hematol; 2017 Mar; 47():76-82.e3. PubMed ID: 27833034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further delineation of bone marrow failure syndrome caused by novel compound heterozygous variants of MYSM1.
    Li N; Xu Y; Yu T; Yao R; Chen J; Luo C; Wang J
    Gene; 2020 Oct; 757():144938. PubMed ID: 32640305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review.
    Fiore A; Liang Y; Lin YH; Tung J; Wang H; Langlais D; Nijnik A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Deubiquitinase 2A-DUB/MYSM1 with DNA Repair and Replication Factors.
    Kroeger C; Roesler R; Wiese S; Hainzl A; Gatzka MV
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of p53 compensates osteopenia in murine Mysm1 deficiency.
    Haffner-Luntzer M; Kovtun A; Fischer V; Prystaz K; Hainzl A; Kroeger CM; Krikki I; Brinker TJ; Ignatius A; Gatzka M
    FASEB J; 2018 Apr; 32(4):1957-1968. PubMed ID: 29203593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficiency in the DNA repair protein ERCC1 triggers a link between senescence and apoptosis in human fibroblasts and mouse skin.
    Kim DE; Dollé MET; Vermeij WP; Gyenis A; Vogel K; Hoeijmakers JHJ; Wiley CD; Davalos AR; Hasty P; Desprez PY; Campisi J
    Aging Cell; 2020 Mar; 19(3):e13072. PubMed ID: 31737985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYSM1/miR-150/FLT3 inhibits B1a cell proliferation.
    Jiang XX; Liu Y; Li H; Gao Y; Mu R; Guo J; Zhang J; Yang YM; Xiao F; Liu B; Wang C; Shen B; Chen SY; Li Z; Yang G
    Oncotarget; 2016 Oct; 7(42):68086-68096. PubMed ID: 27590507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of Krüppel-like factor 14 accelerated cellular senescence and aging.
    Hou Y; Song Q; Wang Y; Liu J; Cui Y; Zhang X; Zhang J; Fu J; Cao M; Zhang C; Liu C; Wang X; Duan H; Wang P
    Aging Cell; 2023 Oct; 22(10):e13950. PubMed ID: 37551728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
    Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
    Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Pharmacological Inhibition of Astrocytic Mysm1 Alleviates Depressive-Like Disorders by Promoting ATP Production.
    Zhang H; Liu S; Qin Q; Xu Z; Qu Y; Wang Y; Wang J; Du Z; Yuan S; Hong S; Chang Z; He W; Yan X; Lang Y; Tang R; Wang Y; Zhu L; Jiang X
    Adv Sci (Weinh); 2022 Nov; 10(1):e2204463. PubMed ID: 36414403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senopathies-Diseases Associated with Cellular Senescence.
    Lushchak O; Schosserer M; Grillari J
    Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor and aging biomarker p16(INK4a) induces cellular senescence without the associated inflammatory secretory phenotype.
    Coppé JP; Rodier F; Patil CK; Freund A; Desprez PY; Campisi J
    J Biol Chem; 2011 Oct; 286(42):36396-403. PubMed ID: 21880712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.